Hindsait Wins Frost & Sullivan Award for Al Healthcare System

27340932281_dc714e2010_b
Apple Unveil AI Plans at WWDC 2016
June 14, 2016
barclays office rs1
Designing AI to Fit Our Customers – Not the Other Way Around: Noel Lyons of Barclays
June 15, 2016

Hindsait Wins Frost & Sullivan Award for Al Healthcare System

5815939421_8a46983157_z
Based on its recent analysis of the market for artificial intelligence systems for the healthcare industry, Frost & Sullivan recognizes Hindsait with the 2016 Global Frost & Sullivan Award for Visionary Innovation Leadership. Hindsait has been recognised for demonstrating a strong commitment to breaking down communication barriers and enhancing healthcare delivery using AI and cognitive computing technology. 

 

Hindsait_logo_with_tagline

 

With its novel software-as-a-service (SaaS) platform, Hindsait helps payers reduce costs and improve the quality of services while simultaneously enabling healthcare providers, such as accountable care organizations (ACOs) and hospitals, to reduce risks and offer superior, more affordable care.

 

“Hindsait’s main goal has been to develop a robust, AI platform that specifically addresses the needs of healthcare organizations,” said Frost & Sullivan Research Analyst Harpreet Singh Buttar. “This platform assists in reducing unnecessary health services, eliminating errors and biases in care delivery and improving overall quality of care.”

 

Hindsait’s system has proven to be highly adaptable and scalable, based on unique use case requirements. Their capabilities range from natural language processing (NLP) and machine learning to cognitive computing and predictive analytics that directly helps providers and payers resolve healthcare delivery issues.

 

Hindsait boasts a wide range of services, right from analysing unstructured data, such as clinical notes, patient charts, and prescriptions, to real-time optimization of diagnostic and treatment plans. Providers and payers employ Hindsait’s SaaS platform to address both administrative and clinical decision-making, which are consistent, auditable and error-free.

 

The SaaS platform is remarkably easy to integrate with providers’ and payers’ existing systems and has an adjustable level of autonomy from a client’s normal data and communication workflows. First, Hindsait’s platform effectively ingests clinical documents across a broad range of formats and structures. It then identifies, rationalizes and extracts clinically relevant data which it turns into actionable intelligence drastically improving the efficacy of Hindsait’s clients’ businesses.

 

For instance, within the realm of utilization management (UM), Hindsait’s SaaS platform scores incoming prior-authorization requests for numerous diagnostic procedures such as magnetic resonance imaging (MRI), computed tomography (CT) scans, and nuclear cardiology exams. Predictive scoring is done in near real time according to each procedure’s established clinical necessity, using relevant information automatically extracted from the patient’s chart. This UM module has reduced unwarranted procedures and patients’ exposure to unnecessary risks, as well as decreased the turnaround time between a request for a procedure by an ordering physician and the final approval or denial of coverage.

 

“Hindsait has demonstrated the vision to anticipate needs before they actually emerge,” noted Buttar. “Its singular focus on creating products and solutions with unique and differentiated benefits that not only improve business performance, but also enhance individuals’ work and personal lives has richly earned the company the 2016 Global Frost & Sullivan Award for Visionary Innovation Leadership.”

 

You can read our interview with Hindsait founder and CEO Pinaki Dasgupta here.

 

For the latest news and conversations about AI in business, follow us on Twitter @Business_AI and join us on LinkedIn – AI Business Community

Embedded image credit: https://www.hindsait.com/

Feature image credit: Flickr

Leave a Reply

Translate »

We use cookies. By browsing our site you agree to our use of cookies.Accept